Assessing Compliance With Mercaptopurine Treatment in Younger Patients With Acute Lymphoblastic Leukemia in First Remission
This randomized phase III trial studies compliance to a mercaptopurine treatment intervention compared to standard of care in younger patients with acute lymphoblastic leukemia that has had a decrease in or disappearance of signs and symptoms of cancer (remission). Assessing ways to help patients who have acute lymphoblastic leukemia to take their medications as prescribed may help them in taking their medications more consistently and may improve treatment outcomes.
Research Base: Children's Oncology Group
NCT ID: NCT01503632
NCI Protocol Number: COG-ACCL1033
Status: Active, not recruiting
For more information see ClinicalTrials.gov
Interventions
- Behavioral Intervention
- Compliance Monitoring
- Laboratory Biomarker Analysis
- Mercaptopurine
- Questionnaire Administration
- Standard Follow-Up Care
Condition
Acute Lymphoblastic Leukemia
Trial Type
Comparative Effectiveness Research
See a list of participating sites on ClinicalTrials.gov